Collecting patient experiences of skin reactions in breast cancer radiotherapy
Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
This study is trying to learn about the skin reactions that breast cancer patients experience during or after radiation treatment to help improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT06953245 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on gathering patient-reported experiences related to radiation dermatitis among individuals diagnosed with breast cancer who are currently undergoing or have recently completed radiotherapy. The study aims to understand the severity and impact of skin reactions caused by radiation treatment. Participants will provide verbal or oral consent to share their experiences, contributing valuable insights into the side effects of radiotherapy. The findings may help improve patient care and management strategies for radiation dermatitis.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with breast cancer and are currently undergoing or have recently completed radiotherapy.
Not a fit: Patients under 18, those unable to provide verbal consent, or non-English speakers without available translations may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of radiation dermatitis, leading to better patient care for those undergoing radiotherapy.
How similar studies have performed: Other studies have explored patient-reported outcomes in cancer treatment, indicating a growing interest in understanding patient experiences, though this specific focus on radiation dermatitis is less commonly addressed.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults ≥ 18 * Patients diagnosed with breast cancer * Currently undergoing or recently completed radiotherapy * Willing to provide verbal/oral consent * Willing to be recorded as they are answering the survey questions Exclusion Criteria: * Persons \< 18 * Inability to provide verbal consent * Non-English speakers (unless translations are available) * Not willing to be recorded
Where this trial is running
Rochester, Minnesota
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Kimberly S. Corbin, MD — Mayo Clinic in Rochester
- Study coordinator: Clinical Trials Referral Office
- Email: mayocliniccancerstudies@mayo.edu
- Phone: 855-776-0015
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.